Sector: MedicalSangamo BioSciences, Inc. (NASDAQ: SGMO)
Headlines
- Sangamo BioSciences Reports Third Quarter 2009 Financial Results
Nov 04, 2009 04:02 PM | SGMO, SIAL
- Sangamo BioSciences Announces Presentation at Merriman Curhan Ford's Investor Summit 2009
Nov 03, 2009 04:06 PM | SGMO
- Sangamo BioSciences Announces Third Quarter 2009 Conference Call and Webcast
Oct 28, 2009 04:06 PM | SGMO
- Sangamo BioSciences Research Collaborators Awarded Grant From California Institute for Regenerative Medicine to Develop Zinc Finger Nuclease-Based Stem Cell Therapy for HIV/AIDS
Oct 28, 2009 04:02 PM | SGMO
- Sangamo BioSciences Announces Presentation of Top-Line Statistically Significant Phase 2 Data in Diabetic Neuropathy at Society for Neuroscience Meeting
Oct 20, 2009 02:00 PM | SGMO
- StockPreacher.com Issues Trading Outlook for GenVec Inc.
Oct 16, 2009 06:51 AM | BIIB, GNVC, SGMO, SGP, SUPG
- Sangamo Announces Closing of Common Stock Offering
Oct 13, 2009 12:30 PM | JEF, SGMO
- Sangamo Announces Pricing of Public Offering of Common Stock
Oct 07, 2009 09:15 AM | JEF, SGMO
- Sigma-Aldrich(R) and Sangamo BioSciences Announce Major Expansion of ZFP Technology License Agreement
Oct 05, 2009 07:01 AM | SGMO, SIAL
- Sangamo BioSciences Announces Research Collaboration With UCLA in Human Stem Cells Selected to Receive Clinical Research Award
Oct 01, 2009 07:01 AM | SGMO
- Sangamo BioSciences Reports Second Quarter 2009 Financial Results
Jul 29, 2009 04:06 PM | SGMO
- OMT Announces a Breakthrough in the Development of a Novel Human Antibody Platform
Jul 23, 2009 02:02 PM | SGMO, SIAL
- Researchers Create First Targeted Knockout Rats Using Zinc Finger Nuclease Technology
Jul 23, 2009 02:01 PM | SGMO, SIAL
- Sangamo BioSciences Announces Second Quarter 2009 Conference Call and Webcast
Jul 22, 2009 04:06 PM | SGMO
- Dyax Corp. Announces Second Quarter 2009 Financial Results
Jul 22, 2009 07:54 AM | CBST, DYAX, SGMO
- Sangamo BioSciences Announces Achievement of Key Milestone in Cell Engineering Agreement With Genentech
Jun 29, 2009 01:00 AM | SGMO
- Sangamo BioSciences Presents Positive Phase 2 ZFP Therapeutic Data at ADA 2009
Jun 08, 2009 07:02 AM | SGMO
- Sangamo BioSciences Announces Presentation at the Needham Life Sciences Conference
Jun 03, 2009 04:05 PM | SGMO
- Sangamo BioSciences Announces Presentation at the JMP Securities Research Conference
May 13, 2009 04:06 PM | SGMO
- Sangamo BioSciences Receives $100,000 Grand Challenges Explorations Grant for Innovative Global Health Research
May 04, 2009 10:06 AM | SGMO
- Form 4 Wolff Henry Ward For: Sep 30 (10K)
Oct 02, 2009 05:56 PM
- Form 4 Wolff Henry Ward For: Jun 30 (10K)
Jul 02, 2009 06:11 PM
- Form 4 GERBER WILLIAM G For: Jun 04 (10K)
Jun 08, 2009 10:21 PM
- Form 4 Mento Steven J For: Jun 04 (10K)
Jun 08, 2009 10:20 PM
- Form 4 Cleveland Paul B For: Jun 04 (10K)
Jun 08, 2009 10:20 PM
- Form 4 WIGGANS THOMAS G For: Jun 04 (10K)
Jun 08, 2009 10:20 PM
- Form 4 LARSON JOHN WILLIAM For: Jun 04 (10K)
Jun 08, 2009 10:16 PM
- Form 4/A Mento Steven J For: Nov 15 (10K)
Feb 09, 2009 06:43 PM
- Form 5 LANPHIER EDWARD O II For: Dec 31 (10K)
Feb 09, 2009 06:42 PM
- Form 4 Ichikawa David G For: Dec 10 (10K)
Dec 12, 2008 06:20 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
SGMO
|
Compare to S&P
|
| YTD |
68.97 %
|
39.57 %
|
| 4 Weeks |
-18.78 %
|
-19.22 %
|
| 12 Weeks |
1.91 %
|
-4.37 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -9.09 %
|
|
EPS Growth in Last Year: 20.00 %
|
|
Sales Growth in Last Quarter: -14.03 %
|
|
Sales Growth in Last Quarter: 8.49 %
|
|
